Correlation Between Crispr Therapeutics and Novo Nordisk
Can any of the company-specific risk be diversified away by investing in both Crispr Therapeutics and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crispr Therapeutics and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crispr Therapeutics AG and Novo Nordisk AS, you can compare the effects of market volatilities on Crispr Therapeutics and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crispr Therapeutics with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crispr Therapeutics and Novo Nordisk.
Diversification Opportunities for Crispr Therapeutics and Novo Nordisk
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Crispr and Novo is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Crispr Therapeutics AG and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Crispr Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crispr Therapeutics AG are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Crispr Therapeutics i.e., Crispr Therapeutics and Novo Nordisk go up and down completely randomly.
Pair Corralation between Crispr Therapeutics and Novo Nordisk
Given the investment horizon of 90 days Crispr Therapeutics is expected to generate 2.78 times less return on investment than Novo Nordisk. In addition to that, Crispr Therapeutics is 1.66 times more volatile than Novo Nordisk AS. It trades about 0.01 of its total potential returns per unit of risk. Novo Nordisk AS is currently generating about 0.02 per unit of volatility. If you would invest 6,790 in Novo Nordisk AS on October 20, 2024 and sell it today you would earn a total of 1,079 from holding Novo Nordisk AS or generate 15.89% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crispr Therapeutics AG vs. Novo Nordisk AS
Performance |
| Timeline |
| Crispr Therapeutics |
| Novo Nordisk AS |
Crispr Therapeutics and Novo Nordisk Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crispr Therapeutics and Novo Nordisk
The main advantage of trading using opposite Crispr Therapeutics and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crispr Therapeutics position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
| Novo Nordisk vs. Regeneron Pharmaceuticals | Novo Nordisk vs. Crispr Therapeutics AG | Novo Nordisk vs. Sarepta Therapeutics | Novo Nordisk vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |